ICU Medical, Inc. (NASDAQ:ICUI) Director George A. Lopez sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $205.83, for a total value of $1,029,150.00. Following the completion of the sale, the director now directly owns 573,916 shares in the company, valued at approximately $118,129,130.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Shares of ICU Medical, Inc. (NASDAQ ICUI) traded down $7.15 during trading hours on Monday, hitting $204.00. The stock had a trading volume of 151,010 shares, compared to its average volume of 126,907. ICU Medical, Inc. has a one year low of $127.00 and a one year high of $218.45. The firm has a market cap of $4,250.56, a price-to-earnings ratio of 82.80, a PEG ratio of 3.39 and a beta of 0.36. The company has a debt-to-equity ratio of 0.07, a current ratio of 4.65 and a quick ratio of 3.01.
ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Thursday, November 9th. The medical instruments supplier reported $1.12 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.77 by $0.35. The company had revenue of $343.20 million for the quarter, compared to analyst estimates of $328.56 million. ICU Medical had a return on equity of 4.81% and a net margin of 2.79%. ICU Medical’s revenue for the quarter was up 253.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.35 EPS. equities research analysts anticipate that ICU Medical, Inc. will post 3.95 EPS for the current fiscal year.
Several analysts have recently weighed in on the company. Zacks Investment Research raised ICU Medical from a “hold” rating to a “buy” rating and set a $232.00 price objective on the stock in a report on Thursday, November 16th. Gabelli reissued a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. BidaskClub raised ICU Medical from a “sell” rating to a “hold” rating in a report on Friday, August 18th. Finally, KeyCorp assumed coverage on ICU Medical in a report on Tuesday, October 17th. They set a “sector weight” rating on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $232.00.
Hedge funds have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in ICU Medical by 10.3% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock valued at $122,000 after buying an additional 66 shares in the last quarter. Riverhead Capital Management LLC boosted its stake in ICU Medical by 99.8% in the 2nd quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 499 shares in the last quarter. Victory Capital Management Inc. boosted its stake in ICU Medical by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock valued at $181,000 after buying an additional 157 shares in the last quarter. Eagle Boston Investment Management Inc. acquired a new stake in ICU Medical in the 3rd quarter valued at $200,000. Finally, Parametrica Management Ltd acquired a new stake in ICU Medical in the 2nd quarter valued at $213,000. 78.15% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: This story was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/04/insider-selling-icu-medical-inc-icui-director-sells-1029150-00-in-stock.html.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.